dalteparin has been researched along with Ventricular Fibrillation in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Ventricular Fibrillation: A potentially lethal cardiac arrhythmia that is characterized by uncoordinated extremely rapid firing of electrical impulses (400-600/min) in HEART VENTRICLES. Such asynchronous ventricular quivering or fibrillation prevents any effective cardiac output and results in unconsciousness (SYNCOPE). It is one of the major electrocardiographic patterns seen with CARDIAC ARREST.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Väisänen, O | 1 |
| Mäkijärvi, M | 1 |
| Silfvast, T | 1 |
1 other study available for dalteparin and Ventricular Fibrillation
| Article | Year |
|---|---|
Prehospital thrombolysis perfomed by a ship's nurse with on-line physician consultation.
Topics: Aged; Emergency Medical Services; Emergency Nursing; Enoxaparin; Female; Fibrinolytic Agents; Humans | 2005 |